<code id='BAAF852710'></code><style id='BAAF852710'></style>
    • <acronym id='BAAF852710'></acronym>
      <center id='BAAF852710'><center id='BAAF852710'><tfoot id='BAAF852710'></tfoot></center><abbr id='BAAF852710'><dir id='BAAF852710'><tfoot id='BAAF852710'></tfoot><noframes id='BAAF852710'>

    • <optgroup id='BAAF852710'><strike id='BAAF852710'><sup id='BAAF852710'></sup></strike><code id='BAAF852710'></code></optgroup>
        1. <b id='BAAF852710'><label id='BAAF852710'><select id='BAAF852710'><dt id='BAAF852710'><span id='BAAF852710'></span></dt></select></label></b><u id='BAAF852710'></u>
          <i id='BAAF852710'><strike id='BAAF852710'><tt id='BAAF852710'><pre id='BAAF852710'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:33847
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Feds fine Medicare Advantage plans for overcharging members
          Feds fine Medicare Advantage plans for overcharging members

          AdobeThefederalgovernmenthasstartedpenalizingMedicareAdvantageinsurersthathaveonecommon,glaringprobl

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Canadians with cystic fibrosis outlive Americans by a decade

          Michel,acysticfibrosispatientfromMascouche,Québec,Canada,seenhereatoneoftheclinicsthatcontributeddat